NLRP3 Protein Inhibitors Pipeline Research Report 2024: Therapeutic Assessment of 25+ Drugs by Product Type, Stage, Route of Administration, and Molecule Type
21 nov. 2024 04h21 HE
|
Research and Markets
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "NLRP3 Protein Inhibitors - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.The report provides...
Over 15 ATR Protein Inhibitors in Clinical Trials, Signifying Significant Advancements in Cancer Pharmaceutical Research
09 nov. 2023 06h43 HE
|
Research and Markets
Dublin, Nov. 09, 2023 (GLOBE NEWSWIRE) -- The "Global ATR Protein Inhibitors Clinical Trials & Market Opportunity Insight 2024" report has been added to ResearchAndMarkets.com's offering. A...